In addition, a lot of new prognostic genes are exploited for diagnosing and curing breast cancer, such as breast cancer 1/2, TP53, cyclin D1, cyclin E, cathepsin D, cystatin E/M, and plexin B1 (6–8). This evidence concerns the gene TP53 and breast carcinoma.